about
Glycoprotein IIb-IIIa inhibitors for acute ischaemic strokeMultiple versus one or more antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attackExternal counterpulsation for acute ischaemic strokeEdaravone for acute ischaemic strokeAspirin intake and survival after breast cancerComparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological studyComparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological studyTherapeutic Potential of Transdermal Glyceryl Trinitrate in the Management of Acute Stroke.The thrombomodulin analog Solulin promotes reperfusion and reduces infarct volume in a thrombotic stroke model.Declining 1-year case-fatality of stroke and increasing coverage of vascular risk management: population-based cohort studyMorphology of platelet Golgi apparatus and their significance after acute cerebral infarctionDual antiplatelet therapy in secondary prevention of ischemic stroke: a ghost from the past or a new frontier?Targeting aspirin in acute disabling ischemic stroke: an individual patient data meta-analysis of three large randomized trials.Explaining the Decrease of In-Hospital Mortality from Ischemic StrokeAntiplatelet resistance and thromboembolic complications in neurointerventional procedures.Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Estimating the potential contribution of stroke treatments and preventative policies to reduce the stroke and ischemic heart disease mortality in Turkey up to 2032: a modelling study.Anticoagulant therapy for ischemic stroke: A review of literature.Associations between the organisation of stroke services, process of care, and mortality in England: prospective cohort studyEffect of Treatment Delay, Stroke Type, and Thrombolysis on the Effect of Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome after Acute Stroke: A Systematic Review and Meta-Analysis of Individual Patient from Randomised Trials.Cerebrovascular disease in South Asia - Part II: Risk factors and prevention.Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association.Antiplatelet drug resistance is associated with early neurological deterioration in acute minor ischemic stroke in the Chinese population.Changing Management of Acute Ischaemic Stroke: the New Treatments and Emerging Role of Endovascular Therapy.Suicide Prevention in an Emergency Department Population: The ED-SAFE Study.Preventing deep vein thrombosis after stroke: strategies and recommendations.Unmet Needs in Anticoagulant Therapy: Potential Role of Rivaroxaban.Appropriateness of administration of nasogastric medication and preliminary intervention.Heart-breaking aspirin interruption.
P2860
Q24198012-6CA0F414-A85A-4AFD-8189-A575CFF43DF4Q24201386-F5298AE9-CCA5-4482-8290-2082BAE69319Q24203891-7B4DD4E0-9BB8-4F35-BFE8-523C4D81016AQ24234306-0E5D6A9B-3590-4BDC-BB11-787DCD4522B0Q24604280-A30BC379-BB87-4A2E-8872-DA541F90ACB7Q26782126-A4AC51C6-E46C-4752-B28C-8AC41B3BA0DBQ28677533-79ACD5DF-3119-4E89-9798-8338871F48D6Q30490373-CBABF7AC-1A65-458B-99E4-058D6863D1B7Q33924274-9EB6495F-C01A-486C-9891-3A4B7F72BB09Q34064472-B9F2A805-2EAB-4526-A4B7-5D60A0C78603Q34095511-0A8F7592-0094-460C-A1B1-E5D4C287C006Q34479105-D4237EA7-8820-4407-9440-D46BF1836414Q35599689-20C5DBFE-6726-4FEA-AC49-8FE48243E9CBQ35686143-1223411D-E45C-46D5-88A9-49CC1AC3EBE4Q35750126-7DBA44C3-5564-43FC-B21E-EEF8129FBBD1Q35752603-8683BA79-AD4D-47A5-993B-2E926C8397EEQ35897075-E0AFA2AD-9996-43E6-B2CD-515174EE23DEQ36477578-389EAAA4-7017-481C-8228-EBD1CE4246A2Q36834211-D31AB7ED-C8DD-4E60-9447-12159EF38DEEQ36854734-BF415C4D-71BE-4B44-A735-29F032E8AACBQ37082601-9CABC88A-9EC1-400C-97EC-14BDE9894654Q38169038-C67F7704-D2BD-4E91-9B59-D86DC74948A7Q38391708-81E459AA-A41D-4003-B164-F3A34F053CEAQ38790291-5EC1D07D-0FAD-4836-AF1C-D770B5C59475Q38813098-29C82CD2-B29E-4055-8C1F-E92FFA57A38AQ38923015-86DD725A-5371-4B09-9C05-58E5AD0398B6Q39135634-A6179056-7455-45BE-B800-71242397089BQ42055284-154120DB-4799-4472-B1B3-C7595C70D736Q52806304-D0AAA5D8-FA2D-4025-857B-A78FD0DD6FF5
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Antiplatelet therapy for acute ischaemic stroke
@ast
Antiplatelet therapy for acute ischaemic stroke
@en
Antiplatelet therapy for acute ischaemic stroke
@en-gb
Antiplatelet therapy for acute ischaemic stroke
@nl
type
label
Antiplatelet therapy for acute ischaemic stroke
@ast
Antiplatelet therapy for acute ischaemic stroke
@en
Antiplatelet therapy for acute ischaemic stroke
@en-gb
Antiplatelet therapy for acute ischaemic stroke
@nl
prefLabel
Antiplatelet therapy for acute ischaemic stroke
@ast
Antiplatelet therapy for acute ischaemic stroke
@en
Antiplatelet therapy for acute ischaemic stroke
@en-gb
Antiplatelet therapy for acute ischaemic stroke
@nl
P2093
P2860
P3181
P1476
Antiplatelet therapy for acute ischaemic stroke
@en
P2093
Carl Counsell
Gordon J Gubitz
Mei-Chiun Tseng
P2860
P304
P3181
P356
10.1002/14651858.CD000029.PUB2
P577
2008-07-16T00:00:00Z